Fate Therapeutics, Inc. (NASDAQ: FATE) announced today that it has entered into a securities purchase agreement for a private placement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE